You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for TEVA PHARMACEUTICALS USA, INC. v. BIOGEN INTERNATIONAL GMBH (D.N.J. 2023)

✉ Email this page to a colleague

« Back to Dashboard

TEVA PHARMACEUTICALS USA, INC. v. BIOGEN INTERNATIONAL GMBH (D.N.J. 2023)

Docket	⤷ Sign Up	Date Filed	2023-05-05
Court	District Court, D. New Jersey	Date Terminated
Cause	28:1332 Diversity-Breach of Contract	Assigned To	Michael E. Farbiarz
Jury Demand	Plaintiff	Referred To	Jose R. Almonte
Patents	8,399,514
Link to Docket	External link to docket

Small Molecule Drugs cited in TEVA PHARMACEUTICALS USA, INC. v. BIOGEN INTERNATIONAL GMBH

The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .

Details for TEVA PHARMACEUTICALS USA, INC. v. BIOGEN INTERNATIONAL GMBH (D.N.J. 2023)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2023-05-05	1	Complaint	25. Biogen owns United States Patent 8,399,514 (the ‘514 Patent). 26. Biogen manufactures…the ‘514 patent. 29. In response to Mylan’s ANDA filing, Biogen sued Mylan for patent infringement…own financial losses in the wake of unsuccessful patent litigation on Tecfidera® and market challenges … 28. Under the Drug Price Competition and Patent Term Restoration Act of 1984 (the Hatch-Waxman…, seeking a declaratory judgment that the ‘514 Patent was invalid and not infringed. 30. Following	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.